Human Genome Epidemiology Literature Finder
|
Records 1 - 2 (of 2 Records) |
| Query Trace: Neoplasms and OLAH[original query] |
|---|
| Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Sep 31 (25): 3091-9. Phillips Kelly-Anne, Milne Roger L, Rookus Matti A, Daly Mary B, Antoniou Antonis C, Peock Susan, Frost Debra, Easton Douglas F, Ellis Steve, Friedlander Michael L, Buys Saundra S, Andrieu Nadine, Noguès Catherine, Stoppa-Lyonnet Dominique, Bonadona Valérie, Pujol Pascal, McLachlan Sue Anne, John Esther M, Hooning Maartje J, Seynaeve Caroline, Tollenaar Rob A E M, Goldgar David E, Terry Mary Beth, Caldes Trinidad, Weideman Prue C, Andrulis Irene L, Singer Christian F, Birch Kate, Simard Jacques, Southey Melissa C, Olsson Håkan L, Jakubowska Anna, Olah Edith, Gerdes Anne-Marie, Foretova Lenka, Hopper John |
| A common genetic variation in GZMB may associate with cancer risk in patients with Lynch syndrome. Frontiers in oncology 2023 3 13 1005066. Grolmusz Vince Kornél, Nagy Petra, Likó István, Butz Henriett, Pócza Tímea, Bozsik Anikó, Papp János, Oláh Edit, Patócs Atti |
- Page last reviewed:Feb 1, 2024
- Content source: